North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 -

North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

The North America Non-steroidal Anti-inflammatory Drugs Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).

Throughout the course of the forecast period, market expansion is anticipated to be aided by the rising prevalence of pain-related conditions such as arthritis. For instance, the CDC estimates that around 1 in 4 adults in the United States, or roughly 58.5 million individuals, has been diagnosed with arthritis. Compared to males, women (23.5%) are more likely to have this arthritis than men (18.1 percent). As a result, it is anticipated that the increased incidence of arthritis will support growth during the projection period.

Age-related disorders as CVDs, cancer, arthritis, chronic pain, diabetes, and others are more common in the senior population. Thus, it is anticipated that the market will expand as the global elderly population rises. For instance, a report from the Administration on Ageing (AoA) estimates that the number of Americans 65 and over was approximately 54.1 million in 2019, or more than 16 percent of the country's total population. There were roughly 24.1 million men and about 30 million women among them. By 2040, there will be 21.6 percent of this population in the United States. Therefore, it is anticipated that the growth will be fueled by the ongoing increase in the geriatric population over the forecast period.

Due to reasons like the developed healthcare industry with a big number of well-known firms, significant investment, and the demand for more potent and secure medications, among others, this region with the greatest market for anti-inflammatory pharmaceuticals. In addition, the high income per capita, increase in doctor visits, and breakthroughs in research due to high financing are among the factors boosting the regional market's expansion. The herb arnica is found in several nations of the region. The flowers are being utilized medicinally to treat conditions like osteoarthritis, surgery, sore throats, and other conditions that cause pain. Arnica is frequently applied to treat bleeding, swelling, and bruises.

The US market dominated the North America Non-steroidal Anti-inflammatory Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $6,376.7 Million by 2028. The Canada market is poised to grow at a CAGR of 7.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.6% during (2022 - 2028).

Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Route of Disease Indication, the market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

  • Oral
  • Topical
  • Others
By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
By Disease Indication
  • Arthritis
  • Migraine
  • Ophthalmic Diseases
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Dr. Reddy’s Laboratories Ltd.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Eli Lilly And Company
  • Sanofi S.A.
  • AstraZeneca PLC
  • Viatris, Inc.
  • Merck & Co., Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
1.4.2 North America Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
1.4.3 North America Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
1.4.4 North America Non-steroidal Anti-inflammatory Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market
Chapter 4. North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Topical Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
5.1 North America Retail Pharmacy Market by Country
5.2 North America Hospital Pharmacy Market by Country
5.3 North America Online Pharmacy Market by Country
Chapter 6. North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
6.1 North America Arthritis Market by Country
6.2 North America Migraine Market by Country
6.3 North America Ophthalmic Diseases Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Non-steroidal Anti-inflammatory Drugs Market by Country
7.1 US Non-steroidal Anti-inflammatory Drugs Market
7.1.1 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.1.2 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.1.3 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 Canada Non-steroidal Anti-inflammatory Drugs Market
7.2.1 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.2.2 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.2.3 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 Mexico Non-steroidal Anti-inflammatory Drugs Market
7.3.1 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.3.2 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 Rest of North America Non-steroidal Anti-inflammatory Drugs Market
7.4.1 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.4.2 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.4.3 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trails:
8.4 Bayer AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings